Credited from: ALJAZEERA
The US embassy in New Delhi has announced that it has revoked or denied visas for certain Indian business executives and corporate leaders due to their alleged involvement in the trafficking of fentanyl precursors, which are critical components used in the production of fentanyl. The identities of those affected have not been disclosed, according to Dawn, TRT Global, Al Jazeera, and BBC.
The US embassy stressed that individuals involved in illicit drug trafficking, along with their family members, may be deemed ineligible for travel to the United States. The embassy emphasized its "commitment to fighting illicit drug trafficking" and noted that related cases are legally backed by the Immigration and Nationality Act, as highlighted by TRT Global and BBC.
The announcement aligns with the Trump administration's broader strategy aimed at addressing the rising crisis of synthetic opioid overdoses in the US, a goal described as a top priority. Official statements indicate that the embassy will impose increased scrutiny on executives from companies previously linked to the trafficking of fentanyl precursors, as reported by Al Jazeera and BBC.